Tempo Therapeutics
San Diego
About Tempo Therapeutics
Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine. It provides power to regenerative medicine, providing materials that evade the typical host immune rejection response to build synthetic tissue hybrids from skin to bone to heart to brain.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $16.1M
- Last round: Series Unknown (Sep 2024)
- Website: tempothera.com
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tempo-therapeutics-125082 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.